Recce Pharmaceuticals (RCE) has been granted ethics approval to start a phase one/two study on patients with infected burn wounds sponsored by WA’s South Metropolitan Health Service with Fiona Stanley Hospital as the study site.
Read the full article on The Market Herald.
Recce Pharmaceuticals (ASX:RCE) gains ethics approval to start burns study
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $250.5M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 531 | 46.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 311 | 1 |
View Market Depth
| Last trade - 09.57am 19/08/2024 (20 minute delay) ? |
| DXB (ASX) Chart |
Day chart unavailable